Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Showing posts with label Vancouver. Show all posts
Showing posts with label Vancouver. Show all posts

Thursday, September 10, 2015

Canada: Psychosis, Hepatitis C linked to high death rate in Downtown Eastside: UBC

The mortality rate in the Downtown Eastside is eight times the national average, according to a new UBC study that followed 371 people for about four years. 
 
The death rate in the Downtown Eastside is eight times higher than the Canadian average, and treatable problems are linked to mortality, according to research from the University of British Columbia published last month.

Psychosis and liver problems related to hepatitis C were the highest risk factors for mortality, according to the study of 371 people over about four years.

Researchers recruited the participants from single-room occupancy hotels and the Downtown Community Court. Thirty-one of them died.